Resultados: 2

Cost-effectiveness of moderate-to-severe psoriasis biologic treatments in Brazilian private healthcare system: cost-per-responder results derived from a network metanalysis

Carvalho, André Vicente Esteves de; Duarte, Gleison Vieira; Ianhez, Mayra; Silva, Bruno Leonardo; Biella, Carla de Agostino; Santos, Rafael Freitas dos.

J. bras. econ. saúde (Impr.); 12 (3), 2020

Objective: To assess the cost-per-responder (CpR) of biologic therapies available in Brazil to treat moderate-to-severe plaque psoriasis (PsO) from the private healthcare system’s perspective. Methods: Number needed to treat (NNT) and (CpR) analyses were performed to evaluate biologic therapies’ cost...

Psoríase, Produtos Biológicos, Custos e Análise de Custo, Saúde Suplementar

Texto completo (link principal) Texto completo (link alternativo)

Unveiling atopic dermatitis burden in Brazil: a report from clinical assistance perspective

Mesquita, Kleyton; Colombini, Mariana; Duarte, Gleison; Ferreira, Sineida Berbert; Yang, Ariana; Mallozi, Marcia; Lupi, Omar; Guidacci, Marta; Abreu, Daniel; Paiva, Helder.

J. bras. econ. saúde (Impr.); 11 (2), 2019

Objective: Atopic dermatitis (AD) or atopic eczema is a chronic skin inflammatory disease that involves the interaction between immune, genetic and environmental triggers. AD affects 15%-20% of infants and 1%-4% of adults worldwide although prevalence varies per country. The main objective is to raise th...

Dermatite Atópica, Qualidade de Vida, Terapêutica

Texto completo (link principal) Texto completo (link alternativo)